Sifrol ER Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

SIFROL extended-release tablet 0.375mg: Biconvex, round, white tablets with marking 'P1'.
1 tablet contains 0.375mg of pramipexole dihydrochloride monohydrate equivalent to 0.26mg (S)-2-amino-4,5,6,7-tetrahydro-6-propylamino-benzothiazole (= pramipexole base).
SIFROL extended-release tablet 1.5mg: Biconvex, oval, white tablets with marking 'P3'.
1 tablet contains 1.5mg of pramipexole dihydrochloride monohydrate equivalent to 1.05mg (S)-2-amino-4,5,6,7-tetrahydro-6-propylamino-benzothiazole (= pramipexole base).
Excipients/Inactive Ingredients: Hypromellose 2208, Maize starch, Carbomer 941, Colloidal anhydrous silica, Magnesium stearate.

pramipexole

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH